Evidence map›Paper›PMID 34725903›Full record

ArticleMolecular oncology2022

A standalone approach to utilize telomere length measurement as a surveillance tool in oral leukoplakia.

Jagannath Pal, Yogita Rajput, Shruti Shrivastava, Renuka Gahine, Varsha Mungutwar, Tripti Barardiya, Ankur Chandrakar, Pinaka Pani Ramakrishna, Sovna Shivani Mishra, Hansa Banjara and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecular oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Investigation of the Telomere Length in PERI-Implant Oral Mucosa Cells.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Jagannath PalMulti-Disciplinary Research Unit (MRU), Pt. J.N.M. Medical College, Raipur, Chhattisgarh, India.ORCID 0000-0002-7110-4048
Yogita RajputMulti-Disciplinary Research Unit (MRU), Pt. J.N.M. Medical College, Raipur, Chhattisgarh, India.
Shruti ShrivastavaDepartment of Pathology, Govt. Medical College, Rajnandgaon, Chhattisgarh, India.
Renuka GahineMulti-Disciplinary Research Unit (MRU), Pt. J.N.M. Medical College, Raipur, Chhattisgarh, India.
Varsha MungutwarDepartment of ENT, Dr. B.R.A.M. Hospital & Pt. J.N.M. Medical College, Raipur, Chhattisgarh, India.
Tripti BarardiyaDepartment of Biochemistry, Pt. J.N.M. Medical College, Raipur, Chhattisgarh, India.
Ankur ChandrakarDepartment of ENT, Dr. B.R.A.M. Hospital & Pt. J.N.M. Medical College, Raipur, Chhattisgarh, India.
Pinaka Pani RamakrishnaDepartment of Oral Medicine and Radiology, Govt. Dental College, Raipur, Chhattisgarh, India.
Sovna Shivani MishraDepartment of Oral Medicine and Radiology, Govt. Dental College, Raipur, Chhattisgarh, India.
Hansa BanjaraDepartment of ENT, Dr. B.R.A.M. Hospital & Pt. J.N.M. Medical College, Raipur, Chhattisgarh, India.
Vivek ChoudharyDepartment of Radiotherapy/Regional Cancer Center, Dr. B.R.A.M. Hospital & Pt. J.N.M. Medical College, Raipur, Chhattisgarh, India.
Pradeep K PatraDepartment of Biochemistry, Pt. J.N.M. Medical College, Raipur, Chhattisgarh, India.
Masood A ShammasHarvard (Dana Farber) Cancer Institute and VA Boston Healthcare System, Boston, MA, USA.
Pt. Jawahar Lal Nehru Memorial Medical College · INGovernment Dental College and Hospital · INGovernment Medical College · INVA Boston Healthcare System · US

Funding

Trageting the Multiple Myeloma EpigenomeP50CA100707 · NCI · DANA-FARBER CANCER INSTITUTE · PI ANDERSON, KENNETH C. · 2003 to 2023
$45.0M
MOLECULAR MANIPULATION TO ENHANCE ANTI-MYELOMA RESPONSEI01BX001584 · VA · VA BOSTON HEALTH CARE SYSTEM · PI MUNSHI, NIKHIL C. · 2013 to 2025
–
BLRD VA I01 BX001584NCI NIH HHS P50 CA100707
6 · The paper itself

Abstract

Oral squamous cell carcinoma (OSCC) is often preceded by a white patch on a surface of the mouth, called oral leukoplakia (OL). As accelerated telomere length (TL) shortening in dividing epithelial cells may lead to oncogenic transformation, telomere length measurement could serve as a predictive biomarker in OL. However, due to high variability and lack of a universal reference, there has been a limited translational application. Here, we describe an approach of evaluating TL using paired peripheral blood mononuclear cells (PBMC) as an internal reference and demonstrate its translational relevance. Oral brush biopsy and paired venous blood were collected from 50 male OL patients and 44 male healthy controls (HC). Relative TL was measured by quantitative PCR. TL of each OL or healthy sample was normalized to the paired PBMC sample (TL ratio). In OL patients, the mean TL ratio was significantly smaller not only in the patch but also in distal normal oral tissue, relative to healthy controls without a high-risk oral habit. Dysplasia was frequently associated with a subgroup that showed a normal TL ratio at the patch but significantly smaller TL ratio at a paired normal distal site. Our data suggest that evaluation of TL attrition using a paired PBMC sample eliminates the requirement of external reference DNA, makes data universally comparable and provides a useful marker to define high-risk OL groups for follow-up programs. Larger studies will further validate the approach and its broader application in other premalignant conditions.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsMouth NeoplasmsFemaleHumansLeukocytes, MononuclearLeukoplakia, OralMaleTelomerehigh-risk oral habitsoral canceroral leukoplakiarelative telomere length

Identifiers

PMID34725903
PMCPMC9019888
OpenAlexW3211271908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.